GSK plc
GSK
#197
Rank
NZ$178.67 B
Marketcap
NZ$88.41
Share price
1.66%
Change (1 day)
47.39%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2025 (TTM): NZ$6.17

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.96. In 2024 the company made an earnings per share (EPS) of NZ$2.64 a decrease over its 2023 EPS that were of NZ$5.02.

EPS history for GSK plc from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.17133.66%
2024NZ$2.64-47.35%
2023NZ$5.02-64.2%
2022NZ$14.02182.29%
2021NZ$4.97-18.07%
2020NZ$6.0622.34%
2019NZ$4.9523.9%
2018NZ$4.00140.61%
2017NZ$1.6664.45%
2016NZ$1.01-90.61%
2015NZ$10.76178.12%
2014NZ$3.87-48.11%
2013NZ$7.4622.68%
2012NZ$6.08-11.31%
2011NZ$6.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.20 104.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.85-52.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.14 3.05%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.59 111.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.87 48.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.04-82.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.53-108.90%๐Ÿ‡บ๐Ÿ‡ธ USA